enVVeno Medical Corporation
NVNO
$1.00
$0.033.09%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 12.13M | 11.52M | 11.58M | 11.69M | 10.93M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 23.95M | 23.28M | 23.83M | 23.41M | 22.58M |
| Operating Income | -23.95M | -23.28M | -23.83M | -23.41M | -22.58M |
| Income Before Tax | -23.07M | -21.33M | -21.82M | -21.24M | -20.60M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -23.07 | -21.33 | -21.82 | -21.24 | -20.60 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -23.07M | -21.33M | -21.82M | -21.24M | -20.60M |
| EBIT | -23.95M | -23.28M | -23.83M | -23.41M | -22.58M |
| EBITDA | -23.79M | -23.10M | -23.64M | -23.20M | -22.37M |
| EPS Basic | -1.21 | -1.19 | -1.28 | -1.33 | -1.43 |
| Normalized Basic EPS | -0.76 | -0.79 | -0.86 | -0.91 | -0.97 |
| EPS Diluted | -1.21 | -1.19 | -1.28 | -1.33 | -1.43 |
| Normalized Diluted EPS | -0.76 | -0.79 | -0.86 | -0.91 | -0.97 |
| Average Basic Shares Outstanding | 77.15M | 72.87M | 68.57M | 63.70M | 58.87M |
| Average Diluted Shares Outstanding | 77.15M | 72.87M | 68.57M | 63.70M | 58.87M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |